Get the Stockscreener App
8.12
5.69%
-0.49
After Hours:
7.97
-0.15
-1.85%
Personalis Inc stock is traded at $8.12, with a volume of 1.27M.
It is down -5.69% in the last 24 hours and up +50.65% over the past month.
Personalis Inc is a provider of genomic sequencing and analytics solutions to support the development of personalized cancer vaccines and other next-generation cancer immunotherapies. It has one segment, the sale of sequencing and data analysis services. Its products include ImmunoID NeXT, NeXT Personal, NeXT Dx Test, and other pharma research solutions.
See More
Previous Close:
$8.61
Open:
$8.7
24h Volume:
1.27M
Relative Volume:
1.30
Market Cap:
$720.06M
Revenue:
$73.48M
Net Income/Loss:
$-108.30M
P/E Ratio:
-3.6089
EPS:
-2.25
Net Cash Flow:
$-67.17M
1W Performance:
+10.63%
1M Performance:
+50.65%
6M Performance:
+167.99%
1Y Performance:
+64.37%
1-Day Range:
$8.05
$8.84
1-Week Range:
$7.17
$8.85
52-Week Range:
$2.8262
$8.85
Personalis Inc Stock (PSNL) Company Profile
Name
Personalis Inc
Sector
Industry
Phone
650-752-1300
Address
6600 DUMBARTON CIRCLE, FREMONT, CA
Compare PSNL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
PSNL
Personalis Inc
|
8.12 | 763.51M | 73.48M | -108.30M | -67.17M | -2.25 |
|
TMO
Thermo Fisher Scientific Inc
|
524.80 | 201.90B | 43.21B | 6.58B | 6.17B | 17.28 |
|
DHR
Danaher Corp
|
202.46 | 146.42B | 24.01B | 3.41B | 4.86B | 4.7082 |
|
IDXX
Idexx Laboratories Inc
|
616.15 | 50.30B | 4.04B | 985.66M | 774.34M | 12.01 |
|
A
Agilent Technologies Inc
|
136.62 | 39.72B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
198.17 | 34.51B | 15.70B | 1.24B | 2.01B | 6.9036 |
Personalis Inc Stock (PSNL) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-15-25 | Initiated | Guggenheim | Buy |
| Mar-17-25 | Initiated | Craig Hallum | Buy |
| Feb-06-23 | Upgrade | Needham | Hold → Buy |
| Jan-07-22 | Upgrade | BofA Securities | Neutral → Buy |
| Nov-05-21 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Nov-03-21 | Downgrade | Needham | Buy → Hold |
| Oct-15-21 | Resumed | Cowen | Outperform |
| Sep-20-21 | Reiterated | Needham | Buy |
| May-06-21 | Upgrade | Oppenheimer | Perform → Outperform |
| Jan-28-21 | Initiated | Truist | Buy |
| Jan-04-21 | Downgrade | BofA Securities | Buy → Neutral |
| Nov-12-20 | Reiterated | Needham | Buy |
| Nov-06-20 | Downgrade | Oppenheimer | Outperform → Perform |
| Oct-19-20 | Initiated | Citigroup | Buy |
| Oct-08-20 | Initiated | BTIG Research | Buy |
| Aug-27-20 | Initiated | H.C. Wainwright | Buy |
| Aug-18-20 | Initiated | Needham | Buy |
| Sep-26-19 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jul-15-19 | Initiated | BofA/Merrill | Neutral |
| Jul-15-19 | Initiated | Cowen | Outperform |
| Jul-15-19 | Initiated | Morgan Stanley | Overweight |
| Jul-15-19 | Initiated | Oppenheimer | Outperform |
View All
Personalis Inc Stock (PSNL) Latest News
Analyzing net buyer seller activity in Personalis Inc.Weekly Stock Summary & Long-Term Growth Stock Strategies - newser.com
How to monitor Personalis Inc. with trend dashboardsWeekly Market Outlook & Precise Buy Zone Tips - newser.com
Visual trend scoring systems applied to Personalis Inc.2025 Support & Resistance & Low Risk High Reward Trade Ideas - newser.com
Forecasting Personalis Inc. price range with options dataEarnings Growth Report & Safe Capital Growth Plans - newser.com
Price momentum metrics for Personalis Inc. explained2025 Trading Volume Trends & Fast Gain Stock Trading Tips - newser.com
Personalis, Inc. Hits New 52-Week High of $8.70, Up 557.58% - Markets Mojo
Understanding Personalis Inc.’s price movementPortfolio Return Report & Community Trade Idea Sharing - newser.com
What MACD signals say about Personalis Inc.Quarterly Trade Report & Weekly Momentum Picks - newser.com
Analyzing Personalis Inc. with risk reward ratio chartsDividend Hike & AI Optimized Trading Strategy Guides - newser.com
Personalis (NASDAQ:PSNL) Reaches New 1-Year HighHere's What Happened - MarketBeat
Head-To-Head Review: Parnell Pharmaceuticals (OTCMKTS:PARNF) versus Personalis (NASDAQ:PSNL) - Defense World
Personalis (NASDAQ:PSNL) surges 13% this week, taking three-year gains to 153% - simplywall.st
What analysts say about Personalis Inc 04X stockMarket Timing Techniques & Free Get High Impact Recommendations - earlytimes.in
Exit strategy if you’re trapped in Personalis Inc.Market Movement Recap & Daily Profit Focused Stock Screening - newser.com
Why Personalis Inc. stock could be next big winner2025 Investor Takeaways & AI Driven Price Forecasts - newser.com
What indicators show strength in Personalis Inc.Market Performance Recap & Advanced Technical Signal Analysis - newser.com
Will Personalis Inc. stock outperform tech sector in 2025Market Activity Report & Stepwise Entry and Exit Trade Signals - newser.com
Personalis (NASDAQ:PSNL) Trading 8.9% HigherStill a Buy? - MarketBeat
Volume spikes in Personalis Inc. stock – what they meanJuly 2025 Action & Free Long-Term Investment Growth Plans - newser.com
What drives Personalis Inc stock priceSwing Trading Watchlist & Identify Winning Stocks - earlytimes.in
Goldman Sachs Group Inc. Has $998,000 Stock Position in Personalis, Inc. $PSNL - MarketBeat
Personalis (NASDAQ:PSNL) Upgraded at Wall Street Zen - MarketBeat
Personalis (NASDAQ:PSNL) Trading 7.5% HigherHere's Why - MarketBeat
Acadian Asset Management LLC Reduces Position in Personalis, Inc. $PSNL - MarketBeat
Personalis, Inc. (NASDAQ:PSNL) Receives $7.42 Consensus Price Target from Analysts - MarketBeat
Retail Trends: Is RPTX benefiting from interest rate changesOptions Play & Safe Capital Growth Plans - khodrobank.com
Should you hold or exit Personalis Inc. nowPortfolio Profit Report & Real-Time Buy Zone Alerts - newser.com
Aug Gainers: Will Freedom Holding Corp outperform small cap indexesRisk Management & Low Risk Growth Stock Ideas - khodrobank.com
What earnings revisions data tells us about Personalis Inc.2025 Key Lessons & High Accuracy Investment Signals - newser.com
Personalis Inc Stock (PSNL) Financials Data
Revenue
Net Income
Cash Flow
EPS
Personalis Inc Stock (PSNL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Tachibana Aaron | CFO AND COO |
Jul 28 '25 |
Sale |
6.57 |
641 |
4,211 |
164,458 |
| Tachibana Aaron | CFO AND COO |
May 16 '25 |
Sale |
4.95 |
1,291 |
6,390 |
165,099 |
| Moore Stephen Michael | SVP and Chief Legal Officer |
May 16 '25 |
Sale |
4.95 |
1,675 |
8,291 |
64,200 |
| Chen Richard | CHIEF MEDICAL OFFICER AND EVP |
May 16 '25 |
Sale |
4.95 |
910 |
4,504 |
124,957 |
| Tachibana Aaron | CFO AND COO |
Jan 28 '25 |
Sale |
5.79 |
708 |
4,099 |
166,390 |
| Chen Richard | CHIEF MEDICAL OFFICER AND EVP |
Jan 28 '25 |
Sale |
5.79 |
519 |
3,005 |
123,367 |
| Chen Richard | CHIEF MEDICAL OFFICER AND EVP |
Dec 16 '24 |
Sale |
3.82 |
4,834 |
18,466 |
123,886 |
| Moore Stephen Michael | SVP and Chief Legal Officer |
Dec 16 '24 |
Sale |
3.82 |
1,513 |
5,780 |
65,875 |
| Tachibana Aaron | CFO AND COO |
Dec 16 '24 |
Sale |
3.82 |
6,865 |
26,224 |
167,098 |
| Tachibana Aaron | CFO AND COO |
Nov 18 '24 |
Sale |
3.79 |
1,307 |
4,954 |
173,963 |
0.17%
2.19%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):